Kaewput W, Thongprayoon C, Petnak T, Chewcharat A, Boonpheng B, Bathini T, et al. Inpatient burden and mortality of methanol intoxication in the United States. Am J Med Sci. 2021;361(1):69–74.
Liberski S, Kaluzny BJ, Kocięcki J. Methanol-induced optic neuropathy: a still-present problem. Arch Toxicol. 2022;96(2):431–51.
Article PubMed PubMed Central CAS Google Scholar
Pakravan M, Esfandiari H, Sanjari N, Ghahari E. Erythropoietin as an adjunctive treatment for methanol-induced toxic optic neuropathy. Am J Drug Alcohol Abuse. 2016;42(6):633–9.
Jafarizadeh A, Sobhi N, Abdollahi M, Khamnian Z, Mousavi F, Jabbari S, Jabbari H. Tertiary referral hospital experience of methanol poisoning in the COVID-19 era: a cross-sectional study in Northwestern Iran. Bull Natl Res Centre. 2023;47(1):119.
Jafarizadeh A, Homaie M, Abdollahi M, Niyousha M. Time course study of optical coherence tomography angiography in patients with methanol induced optic neuropathy. BMC Ophthalmol. 2023;23(1):178.
Article PubMed PubMed Central CAS Google Scholar
Zamani N, Hassanian-Moghaddam H, Shojaei M, Rahimian S. Evaluation of the effect of erythropoietin + corticosteroid versus corticosteroid alone in methanol-induced optic nerve neuropathy. Cutan Ocul Toxicol. 2018;37(2):186–90.
Article PubMed CAS Google Scholar
Nurieva O, Diblik P, Kuthan P, Sklenka P, Meliska M, Bydzovsky J, Heissigerova J, Urban P, Kotikova K,Navratil T, Komarc M, Seidl Z, Vaneckova M, Pelclova D, Zakharov S. Progressive chronic retinal axonal loss following acute methanol-induced optic neuropathy: four-year prospective cohort study. Am J Ophthalmol. 2018;191, 100–15. https://doi.org/10.1016/j.ajo.2018.04.015.
Eells JT, Salzman MM, Lewandowski MF, Murray TG. Formate-induced alterations in retinal function in methanol-intoxicated rats. Toxicol Appl Pharmcol. 1996;140(1):58–69.
Dorokhov YL, Shindyapina AV, Sheshukova EV, Komarova TV. Metabolic methanol: molecular pathways and physiological roles. Physiol Rev. 2015;95(2):603–44.
Article PubMed CAS Google Scholar
Tanrivermis Sayit A, Aslan K, Elmali M, Gungor I. Methanol-induced toxic optic neuropathy with diffusion weighted MRI findings. Cutan Ocul Toxicol. 2016;35(4):337–40.
Article PubMed CAS Google Scholar
Sharma R, Marasini S, Sharma AK, Shrestha JK, Nepal BP. Methanol poisoning: ocular and neurological manifestations. Optom Vis Sci. 2012;89(2):178–82.
Kraut JA. Approach to the treatment of methanol intoxication. Am J Kidney Dis. 2016;68(1):161–7.
Article PubMed CAS Google Scholar
Md Noor J, Hawari R, Mokhtar M, Yussof S, Chew N, Norzan N, et al. Methanol outbreak: a Malaysian tertiary hospital experience. Int J Emerg Med. 2020;13:1–7.
Yu-Wai-Man P, Votruba M, Moore A, Chinnery P. Treatment strategies for inherited optic neuropathies: past, present and future. Eye. 2014;28(5):521–37.
Article PubMed PubMed Central CAS Google Scholar
Ahiskali I, Pinar CL, Kiki M, Cankaya M, Kunak CS, Altuner D. Effect of taxifolin on methanol-induced oxidative and inflammatory optic nerve damage in rats. Cutan Ocul Toxicol. 2019;38(4):384–9.
Article PubMed CAS Google Scholar
Permaisuari N, Rahmawati NA, Nusanti S, Thamrin H. Efficacy of high-dose intravenous. steroid treatment in methanol-induced optic neuropathy: A systematic review. Int J Appl Pharm. 2019;11(6):97–100.
Rotenstreich Y, Assia EI, Kesler A. Late treatment of methanol blindness. Br J Ophthalmol. 1997;81(5):416–7.
Article PubMed CAS Google Scholar
Kimakova P, Solar P, Solarova Z, Komel R, Debeljak N. Erythropoietin and its angiogenic activity. Int J Mol Sci. 2017;18(7):1519.
Article PubMed PubMed Central Google Scholar
Tirpe AA, Gulei D, Ciortea SM, Crivii C, Berindan-Neagoe I, Hypoxia. Overview on hypoxia-mediated mechanisms with a focus on the role of HIF genes. Int J Mol Sci. 2019;20(24):6140.
Article PubMed PubMed Central CAS Google Scholar
Landau D, London L, Bandach I, Segev Y. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia. PLoS ONE. 2018;13(5):e0196684.
Article PubMed PubMed Central Google Scholar
Lai YF, Lin TY, Ho PK, Chen YH, Huang YC, Lu DW. Erythropoietin in Optic neuropathies: current future strategies for Optic nerve Protection and Repair. Int J Mol Sci. 2022;23(13):7143.
Article PubMed PubMed Central CAS Google Scholar
Nikkhah H, Golalipour M, Doozandeh A, Pakravan M, Yaseri M, Esfandiari H. The effect of systemic erythropoietin and oral prednisolone on recent-onset non-arteritic anterior ischemic optic neuropathy: a randomized clinical trial. Graefes Arch Clin Exp Ophthalmol. 2020;258(10):2291–7.
Article PubMed CAS Google Scholar
Pakdel F, Sanjari MS, Naderi A, Pirmarzdashti N, Haghighi A, Kashkouli MB. Erythropoietin in treatment of methanol Optic Neuropathy. J Neuroophthalmol. 2018;38(2):167–71.
Pakravan M, Sanjari N. Erythropoietin treatment for methanol optic neuropathy. J Neuroophthalmol. 2012;32(4):325–8.
Tabatabaei SA, Amini M, Haydar AA, Soleimani M, Cheraqpour K, Shahriari M, et al. Outbreak of methanol-induced optic neuropathy in early COVID-19 era; effectiveness of erythropoietin and methylprednisolone therapy. World J Clin Cases. 2023;11(15):3502–10.
Article PubMed PubMed Central Google Scholar
Alrobaian M, Alkhuraiji A, Almohanna R, Alshehri M, Alyahya B. Visual outcome of methanol toxic optic neuropathy after erythropoietin treatment in Riyadh, Saudi Arabia. Saudi J Ophthalmol. 2023.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Reviews. 2021;10(1):89.
Aromataris E, Munn Z. JBI manual for evidence synthesis. Joanna Briggs Institute; 2020.
Ma L-L, Wang Y-Y, Yang Z-H, Huang D, Weng H, Zeng X-T. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Military Med Res. 2020;7(1):7.
Peters M, Godfrey C, McInerney P, Soares C, Khalil H, Parker D. The Joanna Briggs Institute reviewers’ manual 2015: methodology for JBI scoping reviews. 2015.
Nekoueifard S, Majidi M. Subcutaneous erythropoietin reverses Optic Neuropathy Induced by methanol poisoning: three case reports. Iran J Toxicol. 2020;14(3):187–92.
Vafapour F, Jahangiri-Mehr S, Hassanzadeh S. Delayed reversal of methanol-induced blindness in an adult by a combination of erythropoietin and a high dose of methylprednisolone: a case report. J Med Case Rep. 2023;17(1):181.
Article PubMed PubMed Central Google Scholar
Rashidi Alavijeh M, Mazaheri-Tehrani S, Saffari AS, Fazel M, Fazel F. Intravenous plus intravitreal erythropoietin for management of methanol toxicity optic neuropathy: a case report and brief review. Clin Case Rep. 2023;11(3):e7011.
Article PubMed PubMed Central Google Scholar
Shams M, Zaheryany SMS, Bidaki R. Dramatic methanol induced toxic optic neuropathy and dramatically response to erythropoietin: a case report. Clin Case Rep Rev. 2015;1:48–9.
Mohebpour V, Rahimi M, Shadnia S, Mostafazadeh B, Erfan Talab Evini P. The adverse reactions of erythropoietin in methanol toxicity: a descriptive study. Int J Med Toxicol Forensic Med. 2024;14:43078.
Barceloux DG, Randall Bond G, Krenzelok EP, Cooper H, Allister Vale J. American academy of clinical toxicology ad hoc committee on the treatment guidelines for methanol poisoning. J Toxicology: Clin Toxicol. 2002;40(4):415–46.
Thomson KL, Yeo JM, Waddell B, Cameron JR, Pal S. A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography. Alzheimer’s Dementi: Diagn Assess Disease Monit. 2015;1(2):136–43.
Wang J-S, Xie H-T, Jia Y, Zhang M-C. Retinal nerve fiber layer thickness changes in obstructive sleep apnea syndrome: a systematic review and Meta-analysis. Int J Ophthalmol. 2016;9(11):1651.
Comments (0)